Literature DB >> 34905170

Purification of HLA Immunopeptidomes from Human Thymus.

Iñaki Alvarez1.   

Abstract

Mass spectrometry has become an essential technique for the analysis of peptide repertoires presented by MHC molecules to T lymphocytes. Years ago, analyses of MHC peptidomes were performed using a great number of cells, and cell lines were chosen as the main peptide source. Mass spectrometry devices have been improved in terms of sensitivity and resolution, making feasible the analysis of samples with relatively small amounts of cells. Thus, analyses of MHC peptide repertoires from different tissue samples are now available. Here, I describe a protocol to process human thymus samples to purify HLA class I- or HLA-DR-associated peptidomes. For that, cells are lysed using a nonionic detergent together with a mechanical cell rupture. Immunopeptidomes are purified by immunoaffinity chromatography. The peptide pool is fractionated by ionic chromatography. Finally, peptide fragmentation and identification are conducted by LC-MS/MS and the use of MASCOT search engine.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antigen presentation; Human leukocyte antigen (HLA); Immunopeptidome; Mass spectrometry; Thymus

Mesh:

Substances:

Year:  2022        PMID: 34905170     DOI: 10.1007/978-1-0716-1936-0_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway.

Authors:  A Paradela; I Alvarez; M García-Peydró; L Sesma; M Ramos; J Vázquez; J A López De Castro
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  Composition of the HLA-DR-associated human thymus peptidome.

Authors:  Javier A Collado; Iñaki Alvarez; M Teresa Ciudad; Gabriel Espinosa; Francesc Canals; Ricardo Pujol-Borrell; Montserrat Carrascal; Joaquín Abian; Dolores Jaraquemada
Journal:  Eur J Immunol       Date:  2013-07-12       Impact factor: 5.532

3.  Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis.

Authors:  G Malcherek; K Falk; O Rötzschke; H G Rammensee; S Stevanović; V Gnau; G Jung; A Melms
Journal:  Int Immunol       Date:  1993-10       Impact factor: 4.823

4.  Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain.

Authors:  K Fleischhauer; D Avila; F Vilbois; C Traversari; C Bordignon; H J Wallny
Journal:  Tissue Antigens       Date:  1994-11

5.  Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.

Authors:  N Rebai; B Malissen; M Pierres; R S Accolla; G Corte; C Mawas
Journal:  Eur J Immunol       Date:  1983-02       Impact factor: 5.532

6.  Central T cell tolerance: Identification of tissue-restricted autoantigens in the thymus HLA-DR peptidome.

Authors:  Iñaki Alvarez; Javier A Collado; Roger Colobran; Montserrat Carrascal; M Teresa Ciudad; Françesc Canals; Eddie A James; William W Kwok; Martina Gärtner; Bruno Kyewski; Ricardo Pujol-Borrell; Dolores Jaraquemada
Journal:  J Autoimmun       Date:  2015-04-21       Impact factor: 7.094

7.  A subset of HLA-B27 molecules contains peptides much longer than nonamers.

Authors:  R G Urban; R M Chicz; W S Lane; J L Strominger; A Rehm; M J Kenter; F G UytdeHaag; H Ploegh; B Uchanska-Ziegler; A Ziegler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

8.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.